- Safety—sterility, endotoxin control, foreign matter, container-closure integrity, residual solvent
- Purity—impurities, foreign matter, lack of cross-contamination
- Efficacy—particle size, crystal morphology, weight control, shipping studies
- Identity—chemical structure, labeling
- Strength—potency, stability.
Each of these primary considerations must be defined to identify the individual qualification or validation activities required to support the quality attribute in total. Product safety requires many studies, including:
- Aseptic filling capability
- Sterilization of bulk powder
- Sterilization or depyrogenation of glass containers and rubber closures
- Sterilization of product-contact equipment
- Sterilization of utensils
- Filling-isolator decontamination
- Environmental monitoring of the isolator environment
- Water for injection systems at API, and fill–finish facility (i.e., endotoxin control)
- Cleaning of API equipment
- Cleaning of fill–finish equipment
- Cleaning of empty bulk containers
- Cleaning of container or closure
- Bulk-container integrity
- Final product container-closure integrity
- Shipping studies
- Validation of API drying.
Product purity requires attention to:
- Impurity profiles
- API process validation
- API equipment cleaning
- Foreign-matter removal
- Absence of cross-contamination from prior products
- Cleaning validation for API
- Cleaning validation for fill–finish equipment
- Bulk-container preparation
- Container preparation
- Stopper washing
- Vial washing.
Efficacy mandates attention to:
- Particle size (i.e., crystallization process)
- Crystal morphology
- API process validation
- Suitability with filling equipment
- Weight control
- Filling equipment qualification
- Shipping studies
- Effect of pressure, temperature, and relative humidity
- Bulk-powder stability (pre and poststerilization)
- Filled-container stability.
No comments:
Post a Comment